Infection Control Market

Global Infection Control Market:

The global infection control market size reached USD 28.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. North America dominates the market because of robust healthcare infrastructure and widespread adoption of sterilization and disinfection technologies. Moreover, the rapid technological advancements in diagnostic and infection control equipment, the increasing demand in veterinary and animal care settings, rising R&D in infectious disease prevention, and the growing focus on preventing healthcare-associated infections (HAIs) are some of the factors propelling the market growth.

Market Size & Forecasts:

• Infection control market was valued at USD 28.1 Billion in 2024.
• The market is projected to reach USD 49.7 Billion by 2033, at a CAGR of 6.22% from 2025-2033.

Dominant Segments:

• Type: Consumables (disinfectants, sterilization consumables, personal protective equipment, and others) lead the market share because of their steady demand in different medical environments. Their disposable characteristic guarantees cleanliness, minimizes contamination chances, and aids in adhering to safety regulations. Moreover, the growing emphasis on hygiene and precautionary practices in healthcare settings strengthens the prevalence of consumables in the market.
• End User: Hospitals and clinics account for the largest market share attributed to their substantial patient turnover, intricate procedures, and stringent cleanliness standards. Their dedication to ensuring a secure clinical setting, compliance with regulatory standards, and focus on quality care greatly enhance their prominent status in the industry.
• Region: North America dominates the infection control market owing to its robust healthcare infrastructure, significant investments in medical technology, and strict enforcement of health standards. Continuous innovation, proficient healthcare workers, and broad implementation of optimal practices further support the area's role as the leading contributor to the infection control market.

 Key Players:

• The leading companies in infection control market include 3M Company, Advanced Sterlization Products Services Inc. (Fortive Corporation), Belimed AG (Metall Zug), Cantel Medical Corp., Getinge AB, Matachana, Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.), MMM Münchener Medizin Mechanik GmbH, Pal International, Sterigenics U.S. LLC (Sotera Health Holdings LLC), Steris Corporation, and TSO3 Inc. (Stryker Corporation).

Key Drivers of Market Growth:

• Growing Aging Population: The rising geriatric population, which is more prone to infections, is driving the need for infection control in healthcare environments. This demographic trend fosters sustained market growth because of an increased demand for rigorous hygiene standards, enhanced sterilization methods, and ongoing preventive care in hospitals and long-term care settings.
• Rising Prevalence of HAIs: The increasing occurrence of infections linked to healthcare is catalyzing the demand for efficient infection control strategies. Healthcare facilities are allocating resources to cutting-edge disinfection methods to enhance patient safety, minimize complications, and comply with regulatory requirements.
• Outpatient Growth: The rising trend of outpatient care is driving the demand for infection control solutions because of high patient turnover and the necessity for safe, effective treatment settings. These establishments need dependable sterilization and hygiene measures, fostering consistent growth in the infection control sector as outpatient services keep expanding.
• Technology Advancement: Improvements in disinfection and sterilization technology are enhancing precision, effectiveness, and safety in controlling infections. Automated processes, intelligent systems, and improved materials are minimizing human errors, boosting compliance, and facilitating reliable results. These advancements are promoting broader acceptance and enhancing market growth throughout various healthcare settings.
• Government Initiatives Supporting Safety: Public health initiatives led by the government are enhancing infection control through the promotion of hygiene awareness, the responsible use of antimicrobials, and adherence to clinical best practices. These initiatives promote institutional advancements, enhance monitoring, and drive the need for infection control products.
• Industry Collaboration: Partnerships among medical device firms and healthcare entities are enhancing access to cutting-edge technologies, promoting education, and unifying efforts toward worldwide safety objectives. These collaborations increase awareness, promote responsible practices, and elevate infection prevention standards across various clinical environments and locations.

Future Outlook:

• Strong Growth Outlook: The infection control market is expected to see significant growth, supported by heightened awareness, growing healthcare needs, and ongoing innovations in sterilization and disinfection technologies. Supportive regulatory environments and increased focus on patient safety foster ongoing growth and enhanced implementation of infection control practices in various healthcare environments.
• Market Evolution: The infection control market is experiencing considerable change, characterized by ongoing innovation and the incorporation of advanced solutions. Increasing focus on preventive health measures and better adherence to global standards are promoting improved practices. This advancement enhances efficiency, safety, and sustainable progress in healthcare provision globally.

Awareness about hygiene and safety among the public and institutions is rising considerably. Healthcare providers emphasize sterilization and hygiene to avoid cross-contamination. This consciousness spreads to patients, motivating institutions to allocate more resources to infection control. The drive for safer surroundings is consistently driving the need for enhanced products and protocols in the industry. Furthermore, ongoing advancements in disinfection tools and supplies are enhancing both their efficacy and user-friendliness. Automated sterilization systems, enhanced chemical formulations, and real-time monitoring tools are now easily available. These innovations improve results while lowering labor and long-term expenses, making them appealing investments for contemporary healthcare operations. Besides this, the increase in elective and emergency surgeries results in a greater need for sterile environments. Surgical suites necessitate rigorous infection control measures, involving a wide array of supplies and instruments. With the rise in surgical volumes, the necessity for uniform infection control grows, making it a key area of focus for healthcare institutions.

Infection Control Market Trends:

Increasing Geriatric Population

There has been a notable rise in the global geriatric population, which plays a crucial role in shaping the infection control market. As projected by the World Health Organization (WHO), by the year 2030, one in six people globally will be aged 60 and above, with the worldwide senior population anticipated to rise from 1 billion in 2020 to approximately 1.4 billion by 2030. By the year 2050, this figure is expected to be around 2.1 billion. This change in demographics directly affects healthcare systems, as older individuals commonly exhibit weaker immune responses and increased vulnerability to infections. As a result, the need for strict infection control measures in hospitals, nursing homes, and long-term care facilities is growing consistently. Upholding rigorous hygiene standards and implementing cutting-edge sterilization methods are crucial in managing this age demographic. These factors further positively influence the infection control market forecast.

Rising Prevalence of Healthcare-Associated Infections (HAI)

The growing frequency of healthcare-associated infections (HAIs) in hospitals and clinical environments in different areas is emerging as a significant issue, considerably driving the need for efficient infection control strategies. Frequent forms of HAIs, including surgical site infections, catheter-related infections, and ventilator-related pneumonia, represent significant health dangers to patients and lead to prolonged hospitalizations, rising healthcare costs, and elevated morbidity rates. A publication from the European Centre for Disease Prevention and Control indicates that nearly 4.3 million hospital patients in the EU/EEA acquire at least one HAI each year. This concerning statistic highlights the critical necessity for improved infection prevention measures and the implementation of cutting-edge disinfection and sterilization technologies. Healthcare providers are progressively allocating resources to infection control products to guarantee patient safety and adhere to rigorous regulatory requirements. The increasing focus on lowering infection rates is strengthening the growth of the infection control industry.

Expanding Ambulatory Services Industry

The increasing transition towards outpatient services is becoming a major factor in driving the demand for infection control products and technologies. These outpatient care centers, providing medical services without the need for overnight hospital admissions, are becoming more popular because of their convenience, affordability, and accessibility. As reported by IMARC Group, the worldwide ambulatory services market attained a valuation of US$ 3.8 Trillion in 2023 and is expected to expand to US$ 6.3 Trillion by 2032, with a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032. As a result of this expansion, the number of patients receiving care in outpatient settings is increasing, which heightens the need for strict infection control measures. Due to high patient turnover, swift treatment cycles, and the necessity to avert cross-contamination, these facilities demand dependable sterilization, surface disinfection, and personal protective measures. The rising emphasis on safety and regulatory adherence in outpatient settings is anticipated to boost the infection control market revenue.

Infection Control Market Growth Drivers:

Technological Advancement and Product Innovation

Advancements in technology for disinfection and sterilization are transformed the infection control market, enhancing its precision, efficiency, and compatibility with changing clinical needs. Advancements in materials, automated systems, chemical substances, and monitoring platforms are enhancing reliability and safety in infection control. A prominent instance is the 2024 introduction of Getinge’s Poladus 150, a low-temperature VH₂O₂ sterilizer designed specifically for heat-sensitive surgical tools. It featured cutting-edge cross-contamination prevention technology designed to minimize healthcare-related infections while optimizing processes in sterile supply units. The system also connected with digital platforms, providing improved traceability and operational effectiveness during hospital reprocessing. Such innovations enable healthcare personnel to execute sterilization procedures with improved uniformity and reduced mistakes. The focus on automation, traceable systems, and intuitive interfaces is minimizing labor-heavy tasks and enhanced adherence to regulations. With increasing awareness among healthcare providers regarding the cost and safety advantages of these technologies, their adoption is accelerating.

Public Health Campaigns and Government Initiatives

Public health campaigns and policy initiatives led by the government are vital in enhancing infection control measures. These initiatives enhance awareness about hygiene, encourage responsible use of antimicrobials, and advocate for best practices in clinical and community environments. Governing bodies frequently assign resources to enhance infection control systems in public hospitals, provide incentives for adherence, and back surveillance initiatives that track infection patterns. National healthcare strategies are progressively prioritizing infection prevention as a key goal, making sure that institutions align with wider health objectives. Educational outreach aimed at both healthcare professionals and the general public reinforces behavior modifications that help lower transmission risks. These campaigns also increase the demand for standardized items, such as disinfectants, sterilization devices, and protective gear. These initiatives enhance public safety while generating ongoing demand, especially in developing areas where awareness and infrastructure are still growing.

Industry Collaboration

Collaborative efforts between manufacturers of medical devices and healthcare stakeholders are essential in promoting the expansion of the infection control market. These collaborations promote awareness, education, and availability of cutting-edge technologies that tackle critical healthcare issues, especially in preventing infections. A recent instance is the collaborative effort by Bactiguard and BD at CRITICARE 2025 in India, where both organizations highlighted the significance of addressing healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), especially in intensive care settings. Throughout the event, clinical sessions emphasized the advantages of Bactiguard-coated catheters in decreasing catheter-associated urinary tract infections (CAUTI) and promoting responsible antibiotic usage. BD has also revealed the imminent release of these cutting-edge devices in the Indian market. These initiatives not only introduce advanced technologies to areas with significant needs but also strengthen the importance of industry partnerships in promoting worldwide infection control objectives, improving patient safety, and broadening market access.

Global Infection Control Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global infection control market report, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on type and end user.

Breakup by Type:

• Equipment
  • Disinfectors
    • Washers
    • Flushers
    • Ultrasonic Cleaners
  • Sterilization Equipment
    • Heat Sterilization
    • Low Temperature Sterilization 
    • Radiation Sterilization
    • Filtration-Based Sterilization
  • Others
• Services
  • Contract Sterilization
    • ETO Sterilization
    • Gamma Sterilization 
    • E-Beam Sterilization
    • Steam Sterilization
  • Infectious Waste Disposal
• Consumables
  • Disinfectants
  • Sterilization Consumables
  • Personal Protective Equipment
  • Others

Consumables dominate the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes equipment (disinfectors (washers, flushers, and ultrasonic cleaners), sterilization equipment (heat sterilization, low temperature sterilization, radiation sterilization, and filtration-based sterilization) and others), services (contract sterilization (ETO sterilization, gamma sterilization, e-beam sterilization, and steam sterilization), and infectious waste disposal), and consumables (disinfectants, sterilization consumables, personal protective equipment, and others). According to the report, consumables represented the largest segment.

According to the infection control market outlook, the consumables segment, including disinfectants, sterilization consumables, personal protective equipment (PPE), and other related products, is the largest market segment in the industry. These consumables play a critical role in preventing and controlling the spread of infections across various sectors, such as healthcare, food processing, and public spaces. Disinfectants are vital in healthcare facilities, laboratories, and public spaces to eliminate harmful pathogens on surfaces and minimize the risk of infections. Sterilization consumables, like autoclave bags and indicator tapes, are indispensable in maintaining sterile medical instruments and equipment conditions.

Breakup by End User:

• Hospitals and Clinics
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others

Hospitals and clinics dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, medical device companies, clinical laboratories, pharmaceutical companies, and others. According to the report, hospitals and clinics represented the largest segment.

According to the infection control market overview, the hospitals and clinics segment emerged as the largest market share holder in the industry, reflecting the critical role of infection prevention measures in healthcare settings. Hospitals and clinics are high-risk environments where vulnerable patients, healthcare professionals, and visitors come into close contact, making them susceptible to infectious diseases. Infection control is of utmost importance in these settings to curb the spread of healthcare-associated infections (HAIs) and safeguard patient safety. Strict protocols, including hand hygiene, sterilization of medical equipment, and the use of personal protective equipment (PPE), are integral to maintaining a safe and sterile environment. Besides this, with a growing focus on patient care, hospital accreditation, and regulatory compliance, the demand for these solutions in hospitals and clinics remains robust. As healthcare facilities strive to enhance infection prevention measures and reduce the burden of HAIs, the hospitals and clinics segment is expected to continue leading the market.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection control market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Russia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

According to the infection control market statistics, North America, comprising the United States and Canada, dominate the market, which can be attributed to several key factors driving its growth. The region's significant aging population contributes to the rising demand for infection control measures. For instance, according to an article published by the Population Reference Bureau, the number of people in the United States aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), with the 65-and-over age group accounting for 17% to 23% of the overall population. Moreover, the region's technologically advanced healthcare infrastructure fosters the adoption of innovative infection control solutions, including advanced disinfectants, sterilization technologies, and smart medical devices.

Competitive Landscape:

Top companies catalyze the market by introducing innovative solutions and technologies to combat infectious diseases. These companies invest heavily in research and development, creating cutting-edge disinfection and sterilization products that effectively prevent the spread of infections. Their commitment to maintaining stringent quality standards and adherence to regulatory guidelines instills trust among healthcare providers, bolstering their market presence. Moreover, these companies actively engage in educational programs and awareness campaigns, emphasizing the importance of infection prevention and control measures. Continued efforts to expand their global footprint through strategic collaborations and acquisitions further fuel market growth. They address environmental concerns and attract environmentally-conscious consumers by prioritizing sustainability and eco-friendly practices.

The infection control market research report has provided a comprehensive analysis of the competitive landscape in the infection control market. Detailed profiles of all major companies have also been provided.

• 3M Company
• Advanced Sterlization Products Services Inc. (Fortive Corporation)
• Belimed AG (Metall Zug)
• Cantel Medical Corp.
• Getinge AB
• Matachana
• Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
• MMM Münchener Medizin Mechanik GmbH
• Pal International
• Sterigenics U.S. LLC (Sotera Health Holdings LLC)
• Steris Corporation
• TSO3 Inc. (Stryker Corporation)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Infection Control Market Recent Developments:

• June 2025: Tristel launched Tristel OPH, an FDA-cleared disinfectant for ophthalmic instruments, at the APIC 2025 infection prevention conference in Boston. The product addresses infection control in ophthalmology and improves workflow efficiency. Tristel also showcased other disinfectants and its digital traceability platform, expanding its US presence.
• June 2025: WHO launched a practical guide to support countries in developing and implementing national action plans (NAPs) for Infection Prevention and Control (IPC), aligned with the Global Action Plan and Monitoring Framework (GAPMF) 2024–2030. The webinar introduced tools, resources, and country examples to inspire action. It targeted IPC professionals and policymakers to promote GAPMF uptake globally.
• March 2025: Egypt’s Health Minister Khaled Abdel Ghaffar announced progress in combating antimicrobial resistance (AMR) at the Second National Conference on Infection Control and AMR. Egypt launched its National Strategy against AMR in 2018 and expanded efforts with a National Antimicrobial Control Plan in 2023. Infection control programs now cover all Ministry-affiliated hospitals, aiming for nationwide compliance.
• October 2024: Infection Control Academy of India in collaboration with the University of Hyderabad and Pragyaan Sustainable Health Outcomes Foundation launched the Global South Conference on Infection Prevention and Control and Antimicrobial Stewardship (G-SPARC) at the Shilpakalavedika convention center, Hyderabad.
• June 2024: The Association for Professionals in Infection Control and Epidemiology (APIC) launched PolicyPro, an infection control and prevention (IPC) policy library and management system of policies, at its 2024 Annual Conference & Exposition.
• May 2024: The ECDC developed a new framework for infectious disease prevention that is focused on social and behavioral sciences, health promotion, health literacy, and health education, with an emphasis on socioeconomic risk factors.

Infection Control Market Report Scope:

Key Questions Answered in This Report:

• How has the global infection control market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global infection control market?
• What is the impact of each driver, restraint, and opportunity on the global infection control market?
• What are the key regional markets?
• Which countries represent the most attractive infection control market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the global infection control market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the global infection control market?
• What is the competitive structure of the global infection control market?
• Who are the key players/companies in the global infection control market?

Key Benefits for Stakeholders:

• IMARC's report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the infection control market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global infection control market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the infection control industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.